FDA Warns Abbott COVID-19 Test May Return False Negatives
Executive Summary
The US FDA issued an alert cautioning the public that Abbott’s widely used rapid test for detecting coronavirus has been linked to false-negative results.
You may also be interested in...
Fact File: European COVID-19 Focus Shifts To Managing The ‘New Normal’
The evolution of how and where patients receive their care has received an unexpected boost from the COVID-19 crisis. Coronavirus volume testing challenges persist, but the global medtech industry is now looking beyond the crisis toward a return to “normal” business.
Abbott Launches Five-Minute POC Rapid COVID-19 Test
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.